24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC

Clinical trial NCT07043270 · RECRUITING

Trial details

NCT number: NCT07043270
Sponsor: Dartmouth-Hitchcock Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Adenocarcinoma

Start date: 2025-09-29
Primary completion: 2028-07-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.